Literature DB >> 31422694

Smooth Muscle Cell-Specific Disruption of the BBSome Causes Vascular Dysfunction.

John J Reho1, Deng-Fu Guo1, Donald A Morgan1, Kamal Rahmouni1,2,3,4,5.   

Abstract

The BBSome-a complex consisting of 8 Bardet-Biedl syndrome proteins-is involved in the regulation of various cellular processes. Recently, the BBSome complex has emerged as an important regulator of cardiovascular function with implications for disease. In this study, we examined the role of the BBSome in vascular smooth muscle and its effects on the regulation of cardiovascular function. Smooth muscle-specific disruption of the BBSome through tamoxifen-inducible deletion of Bbs1 gene-a critical component of the BBSome complex-reduces relaxation and enhances contractility of vascular rings and increases aortic stiffness independent of changes in arterial blood pressure. Mechanistically, we demonstrate that smooth muscle Bbs1 gene deletion increases vascular angiotensinogen gene expression implicating the renin-angiotensin system in these altered cardiovascular responses. Additionally, we report that smooth muscle-specific Bbs1 knockout mice demonstrate enhanced ET-1 (endothelin-1)-induced contractility of mesenteric arteries-an effect reversed by blockade of the AT1 (angiotensin type 1 receptor) with losartan. These findings highlight the importance of the smooth muscle BBSome in the control of vascular function and arterial stiffness through modulation of renin-angiotensin system signaling.

Entities:  

Keywords:  animals; cilia; mice; muscle, smooth; renin-angiotensin system

Mesh:

Substances:

Year:  2019        PMID: 31422694      PMCID: PMC6739154          DOI: 10.1161/HYPERTENSIONAHA.119.13382

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  49 in total

1.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

Review 2.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

3.  Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.

Authors:  Larry N Agbor; Stella-Rita C Ibeawuchi; Chunyan Hu; Jing Wu; Deborah R Davis; Henry L Keen; Frederick W Quelle; Curt D Sigmund
Journal:  JCI Insight       Date:  2016-11-17

4.  ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.

Authors:  M Barton; L V d'Uscio; S Shaw; P Meyer; P Moreau; T F Lüscher
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

5.  Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.

Authors:  Farhad Amiri; Eun A Ko; Danesh Javeshghani; Timothy L Reudelhuber; Ernesto L Schiffrin
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

Review 6.  Hypertension: renin-angiotensin-aldosterone system alterations.

Authors:  Luuk Te Riet; Joep H M van Esch; Anton J M Roks; Anton H van den Meiracker; A H Jan Danser
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

7.  Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor.

Authors:  Yan-Jie Lin; Ching-Fai Kwok; Chi-Chang Juan; Yung-Pei Hsu; Kuang-Chung Shih; Chin-Chang Chen; Low-Tone Ho
Journal:  Biochem Biophys Res Commun       Date:  2014-08-01       Impact factor: 3.575

8.  The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome.

Authors:  J S Green; P S Parfrey; J D Harnett; N R Farid; B C Cramer; G Johnson; O Heath; P J McManamon; E O'Leary; W Pryse-Phillips
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

9.  Mutations in C8ORF37 cause Bardet Biedl syndrome (BBS21).

Authors:  Elise Heon; Gunhee Kim; Sophie Qin; Janelle E Garrison; Erika Tavares; Ajoy Vincent; Nina Nuangchamnong; C Anthony Scott; Diane C Slusarski; Val C Sheffield
Journal:  Hum Mol Genet       Date:  2016-03-22       Impact factor: 6.150

10.  Abnormal development of NG2+PDGFR-α+ neural progenitor cells leads to neonatal hydrocephalus in a ciliopathy mouse model.

Authors:  Calvin S Carter; Timothy W Vogel; Qihong Zhang; Seongjin Seo; Ruth E Swiderski; Thomas O Moninger; Martin D Cassell; Daniel R Thedens; Kim M Keppler-Noreuil; Peggy Nopoulos; Darryl Y Nishimura; Charles C Searby; Kevin Bugge; Val C Sheffield
Journal:  Nat Med       Date:  2012-11-18       Impact factor: 53.440

View more
  7 in total

Review 1.  BBSome: a New Player in Hypertension and Other Cardiovascular Risks.

Authors:  Yuying Zhao; Kamal Rahmouni
Journal:  Hypertension       Date:  2021-12-06       Impact factor: 10.190

2.  Cardiovascular Regulation by the Neuronal BBSome.

Authors:  Deng-Fu Guo; John J Reho; Donald A Morgan; Kamal Rahmouni
Journal:  Hypertension       Date:  2020-03-09       Impact factor: 10.190

3.  mTORC1 (Mechanistic Target of Rapamycin Complex 1) Signaling in Endothelial and Smooth Muscle Cells Is Required for Vascular Function.

Authors:  John J Reho; Deng-Fu Guo; Donald A Morgan; Kamal Rahmouni
Journal:  Hypertension       Date:  2020-12-28       Impact factor: 10.190

Review 4.  Primary Ciliary Signaling in the Skin-Contribution to Wound Healing and Scarring.

Authors:  Mayu Hosio; Viljar Jaks; Heli Lagus; Jyrki Vuola; Rei Ogawa; Esko Kankuri
Journal:  Front Cell Dev Biol       Date:  2020-11-13

5.  Endothelial Cullin3 Mutation Impairs Nitric Oxide-Mediated Vasodilation and Promotes Salt-Induced Hypertension.

Authors:  Jing Wu; Shi Fang; Ko-Ting Lu; Gaurav Kumar; John J Reho; Daniel T Brozoski; Adokole J Otanwa; Chunyan Hu; Anand R Nair; Kelsey K Wackman; Larry N Agbor; Justin L Grobe; Curt D Sigmund
Journal:  Function (Oxf)       Date:  2022-04-08

6.  RhoBTB1 reverses established arterial stiffness in angiotensin II-induced hypertension by promoting actin depolymerization.

Authors:  Shi Fang; Jing Wu; John J Reho; Ko-Ting Lu; Daniel T Brozoski; Gaurav Kumar; Alec M Werthman; Sebastiao Donato Silva; Patricia C Muskus Veitia; Kelsey K Wackman; Angela J Mathison; Bi Qing Teng; Chien-Wei Lin; Frederick W Quelle; Curt D Sigmund
Journal:  JCI Insight       Date:  2022-05-09

7.  ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.

Authors:  Ivan T Lee; Tsuguhisa Nakayama; Chien-Ting Wu; Yury Goltsev; Sizun Jiang; Phillip A Gall; Chun-Kang Liao; Liang-Chun Shih; Christian M Schürch; David R McIlwain; Pauline Chu; Nicole A Borchard; David Zarabanda; Sachi S Dholakia; Angela Yang; Dayoung Kim; Han Chen; Tomoharu Kanie; Chia-Der Lin; Ming-Hsui Tsai; Katie M Phillips; Raymond Kim; Jonathan B Overdevest; Matthew A Tyler; Carol H Yan; Chih-Feng Lin; Yi-Tsen Lin; Da-Tian Bau; Gregory J Tsay; Zara M Patel; Yung-An Tsou; Alexandar Tzankov; Matthias S Matter; Chih-Jaan Tai; Te-Huei Yeh; Peter H Hwang; Garry P Nolan; Jayakar V Nayak; Peter K Jackson
Journal:  Nat Commun       Date:  2020-10-28       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.